This will be Adobe’s biggest challenge in 2025

This will be Adobe’s biggest challenge in 2025

Bulls advise you look past Adobe’s “optically dimmed” forecast, but it certainly raises the bar for next year.

BY Tiernan Ray

This story originally appeared in The Technology Letter and is republished here with permission.

It’s back to pattern for Adobe, which had been selling off for many quarters on its earnings reports, then had a big jump up at the last report, in June, and is now down nine percent Friday, at $532.28, following Thursday evening’s earnings report.

The proximate cause for the decline is the flip side of what drove the shares up in June. The June report saw a better-than-hoped-for forecast for what’s called “net new Digital Media ARR,” the expected value over twelve months of recurring revenue in the company’s main line of business, “Creative Cloud.” Last night’s forecast, in contrast, fell slightly short.

The debate today is how seriously to take that shortfall.

Don’t take it too hard, advises Mark Moerdler of Bernstein, who reiterates his Outperform rating on the stock, and cuts his price target to $644 from $660. He acknowledges that investors are “baffled” because the company in June led them to believe the business was “accelerating” in the latter part of this year.

But, the reasons it hasn’t sped up are minor, in his view, such as foreign exchange effects during the quarter, and also the retail extravaganza known as “Cyber Monday” falling outside of the quarter. All these things made the forecast “optically dimmed,” he writes—which is one of the greatest euphemisms I’ve heard in a while!

Still, Moerdler chides management for not communicating more clearly. “We feel that given the complexity of the business, management should put in more effort to lay out as many meaningful factors ahead of time (e.g. timing shift of holiday season), to avoid issues that would cause unnecessary concerns or nervousness about the stock,” he writes.

“We still hold the view that Adobe’s business remains strong fundamentally, is in a good seat to monetize AI,” concludes Moerdler. However, he’s somewhat tepid on the shares. “While we like the stock longer term, we think that in the short term there lacks a clear catalyst for the stock.”

Other bullish types are also inclined to look past the “moving parts,” but Jackson Ader of KeyBanc, who was cautious back in June, is still concerned.

Every one of the company’s explanations for the shortfall is “plausible” except for the Cyber Monday stuff, he writes, which was known in advance. “But sometimes it isn’t about the particulars, it’s about the aggregate,” he writes. “For all the positive momentum that the Company volunteers on product, innovation and operations, we may have a situation this quarter where the list of reasons looks more like a list of excuses.”

Ader warns that the company might have to sacrifice profit margin if it’s going to maintain growth.

“This has been a key worry for us that many of you are probably tired of hearing,” he writes. “Adobe may have to degrade its margins in order to maintain its revenue growth.

“From the looks of the exit velocity of the metrics this quarter, degradation of margin and growth is now in the cards in FY25 unless the Company’s AI features are able to become material, accelerating revenue to offset the increased innovation costs.”

Indeed, payoff of artificial intelligence is something that has not been showing up for most software companies as hoped this year, and the decline in Adobe’s stock—it is now down ten percent, year to date—is a sign of investors’ disappointment at that. The burden of proof is on Adobe’s AI in 2025.

ANOTHER SHOT IN THE ARM

This has been a good week for ARM Holdings, which got a vote of confidence from Morgan Stanley’s Lee Simpson on Wednesday, and on Friday got a new endorsement as Raymond James analysts Srini Pajjuri initiated coverage of the stock with an Outperform rating, and a $160 price target, which would be ten percent above a recent $146.54. Similar to Simpson, his most immediate point is that the company’s version 9 of its CPU design, ARM’s newest design, is going to be boosted by all the AI being done on devices such as Apple’s iPhone 16. “Edge AI is a key catalyst for ARMv9, which offers ~2x royalties over prior generation and has a long runway,” writes Pajjuri.

However, it’s noteworthy that Pajjuri is also banking on ARM’s invasion of the server processor market, where Intel and Advanced Micro Devices dominate with their x86 instruction set architecture chips. So far, processors using ARM’s alternative have not stormed the server market. But he sees that changing. “While ARM server adoption has been gradual, GenAI is necessitating low-power CPUs and the upcoming NVIDIA GB200 should drive an acceleration,” writes Pajjuri, referring to “generative AI,” which is, indeed, an energy hog; ARM’s designs are generally regarded as vastly more energy-efficient compared to x86. The “GB200” here refers to Nvidia’s newer parts that combine its “Blackwell” GPUs with Nvidia’s “Grace” CPUs, which are based on ARM’s intellectual property. He notes there is a lot of ARM-based chips increasingly showing up, driven partly by AI.

“Arm’s leading-edge Neoverse cores are currently designed into NVIDIA’s GB200 as part of the Grace CPU as well as in processors designed by Google (Axion), Microsoft (Cobalt), and Ampere,” writes Pajjuri. “Custom silicon for hyperscalers is also becoming a strong opportunity for Arm, as we expect custom ASICs to be increasingly paired with ARM CPUs in GenAI clusters.” Pajjuri even makes the striking assertion that “We also see good possibility that ARM will eventually offer data center AI accelerator IP, which could significantly expand its SAM.” Pajjuri’s estimates are roughly in line with consensus.

He notes the stock is trading at sixty-six times fiscal 2026 earnings per share, which is “below its 70x average over the past year.” That’s a high multiple, as he acknowledges. “While we expect the debate regarding valuation to continue, we see little reason for multiple compression in the next 12 months given the strong secular content tailwinds and healthy demand across markets.”

I’m sticking with my view that the stock is too rich. I see better opportunity in Nvidia, trading at less than half what ARM trades for. ARM shares, up five percent today, have almost doubled this year, versus a gain of a hundred and forty percent for Nvidia.

SAGE WORDS TO THE ENOVIX INVESTOR

You may recall that battery technology hopeful Enovix is in the midst of ramping up a new factory in Malaysia while also waiting to hear from customers whether its samples of its batteries will meet their approval for smartphone use. Both of those things have kept investors on tenterhooks this year, as the stock has declined twenty-three percent this year.

Wednesday, Jed Dorsheimer of William Blair, who is a bull on the stock, with an Outperform rating (no price target), hosted a “fireside chat” via Zoom with CEO Raj Talluri and investors. That produced some positive observations from Dorsheimer that he disseminated in a note to clients today. One, the “milestones” for Enovix are “on track,” according to Talluri, including sample batteries coming from the newer “agility” line in the Malaysia factory shipping to customers this quarter, and being ready to operate in high-volume production by the end of this year.

He also notes that Talluri reassured investors Enovix as the capital required to go the distance. Dorsheimer found that particularly reassuring, he writes, as “qualifying and ramping up the first customer is the hardest part of the story.” Beyond that, Dorsheimer offered some sage advice to the nervous investor regarding the “volatility” in the stock.

“We believe the choppiness will remain in the near term as all the company can do between now and a customer PO is execute,” he writes. “With each milestone achieved, the story de-risks further and opens the door wider for large investors to feel more comfortable building core positions. Enovix is an execution story, and we believe Dr. Talluri and his team are true operators and have the ability to achieve scale.”

Get used to it, is basically Dorsheimer’s advice here, and I think he’s right. Investors love the potential for Enovix, but that necessarily comes with nail-biting as well. You either accept that or you go somewhere more mature with your investment dollars. At least it sounds like the things that are within the company’s control are going well, and that’s a good thing.

This story originally appeared in The Technology Letter and is republished here with permission.

 

ABOUT THE AUTHOR

Tiernan Ray is editor of The Technology Letter and is a senior contributing writer at ZDNET. His work has also been published in The New York Times, Fortune, Barron’s and Bloomberg 


Fast Company

(1)